Authors:
Satyanarayana, J
Situ, H
Narasimhamurthy, S
Bhayani, N
Bobek, LA
Levine, MJ
Citation: J. Satyanarayana et al., Divergent solid-phase synthesis and candidacidal activity of MUC7 D1, a 51-residue histidine-rich N-terminal domain of human salivary mucin MUC7, J PEPT RES, 56(5), 2000, pp. 275-282
Citation: H. Situ et al., Role of alpha-helical conformation of histatin-5 in candidacidal activity examined by proline variants, BBA-GEN SUB, 1475(3), 2000, pp. 377-382
Citation: H. Situ et La. Bobek, In vitro assessment of antifungal therapeutic potential of salivary histatin-5, two variants of histatin-5, and salivary mucin (MUC7) domain 1, ANTIM AG CH, 44(6), 2000, pp. 1485-1493
Citation: Cc. Tseng et al., Differential effect toward inhibition of papain and cathepsin C by recombinant human salivary cystatin SN and its variants produced by a baculovirus system, ARCH BIOCH, 380(1), 2000, pp. 133-140
Citation: Tr. Hiltke et al., Structure/function analysis of human cystatin SN and comparison of the cysteine proteinase inhibitory profiles of human cystatins C and SN, J DENT RES, 78(8), 1999, pp. 1401-1409
Citation: Sh. Khan et al., In-situ hybridization localized MUC7 mucin gene expression to the mucous acinar cells of human and MUC7-transgenic mouse salivary glands, GLYCOCON J, 15(12), 1998, pp. 1125-1132